Early in vivo anticoagulation inhibits the angiogenic response following hindlimb ischemia in a rodent model

Thrombosis and Haemostasis

Volumn 96, Issue 1, 2006, Pages 68-72

  De Paula, Erich V ^a   Nascimento, Mariane C F ^a   Ramos, Celso D ^a   Ozelo, Margareth C ^a   Machado, Tânia F ^a   Guillaumon, Ana T ^a   Arruda, Valder R ^b   Annichino Bizzacchi, Joyce M ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Angiogenesis; Anticoagulant; Heparin; Hirudin; Warfarin

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; ENOXAPARIN; LEPIRUDIN; PROTHROMBIN; SODIUM CHLORIDE; THROMBIN; WARFARIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOTTING PARAMETERS; CAPILLARY DENSITY; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DOSE RESPONSE; HINDLIMB; HISTOCHEMISTRY; IN VIVO STUDY; LIMB ISCHEMIA; LIMB PERFUSION; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; REVASCULARIZATION; STEADY STATE; TIME;

ANIMALS; ANTICOAGULANTS; BLOOD COAGULATION FACTORS; DISEASE MODELS, ANIMAL; ENOXAPARIN; HINDLIMB; HIRUDINS; ISCHEMIA; KINETICS; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, INBRED LEW; TIME FACTORS; WARFARIN;

EID: 33746673151     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH06-02-0103     Document Type: Article

References (30)

1. Hughes GC, Annex BH. Angiogenic therapy for coronary artery and peripheral arterial disease. Expert Rev Cardiovasc Ther 2005; 3: 521-35.
2. Sun WY, et al. Prothrombin deficiency results in embryonic and neonatal lethality in mice. Proc Natl Acad Sci USA 1998; 95: 7597-602.
3. Cui J, et al. Fatal haemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor V. Nature 1996; 384: 66-8.
4. Toomey JR, et al. Targeted disruption of the murine tissue factor gene results in embryonic lethality. Blood 1996; 88: 1583-7.
5. Bugge TH, et al. Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation. Proc Natl Acad Sci USA 1996; 93: 6258-63.
6. Griffin CT, et al. A role for thrombin receptor signaling in endothelial cells during embryonic development. Science 2001; 293: 1666-70.
7. Rickles FR, et al. Tissue factor, thrombin, and cancer. Chest 2003; 124: 58S-68S.
8. Wang Y, et al. Vitamin k epoxide reductase: a protein involved in angiogenesis. Mol Cancer Res 2005; 3: 317-23.
9. Takeshita S, et al. Endothelium-dependent relaxation of collateral microvessels after intramuscular gene transfer of vascular endothelial growth factor in a rat model of hindlimb ischemia. Circulation 1998; 98: 1261-3.
10. Paek R, et al. Correlation of a simple direct measurement of muscle pO(2) to a clinical ischemia index and histology in a rat model of chronic severe hindlimb ischemia. J Vasc Surg 2002; 36: 172-9.
11. Takeshita S, et al. Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. Circulation 1994; 90: II228-34.
12. Mack CA, et al. Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion. J Vasc Surg 1998; 27: 699-709.
13. Ziada AM, et al. The effect of long-term vasodilatation on capillary growth and performance in rabbit heart and skeletal muscle. Cardiovasc Res 1984; 18: 724-32.
14. Rissanen TT, et al. Blood flow remodels growing vasculature during vascular endothelial growth factor gene therapy and determines between capillary arterialization and sprouting angiogenesis. Circulation 2005; 112: 3937-46.
15. Hudlicka O, et al. The effect of chronic skeletal muscle stimulation on capillary growth in the rat: are sensory nerve fibres involved? J Physiol 2003; 546: 813-22.
16. Garcia JG, et al. Vascular endothelial cell activation and permeability responses to thrombin. Blood Coagul Fibrinolysis 1995; 6: 609-26.
17. Galis ZS, et al. Thrombin promotes activation of matrix metalloproteinase-2 produced by cultured vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1997; 17: 483-9.
18. Zucker S, et al. Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation. Int J Cancer 1998; 75: 780-6.
19. Huang YQ, et al. Thrombin induces increased expression and secretion of VEGF from human FS4 fibroblasts, DU145 prostate cells and CHRF megakaryocytes. Thromb Haemost 2001; 86: 1094-8.
20. Huang YQ, et al. Thrombin induces increased expression and secretion of angiopoietin-2 from human umbilical vein endothelial cells. Blood 2002; 99: 1646-50.
21. Tsopanoglou NE, Maragoudakis ME. On the mechanism of thrombin-induced angiogenesis. Potentiation of vascular endothelial growth factor activity on endothelial cells by up-regulation of its receptors. J Biol Chem 1999; 274: 23969-76.
22. Senger DR, et al. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin. Am J Pathol 1996; 149: 293-305.
23. Nagy JA, et al. Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition. Biochim Biophys Acta 1989; 948: 305-26.
24. Lee CW, et al. Temporal patterns of gene expression after acute hindlimb ischemia in mice: insights into the genomic program for collateral vessel development. J Am Coll Cardiol 2004; 43: 474-82.
25. Tsopanoglou NE, et al. Thrombin promotes angiogenesis by a mechanism independent of fibrin formation. Am J Physiol 1993; 264: C1302-7.
26. Collen A, et al. Unfractionated and low molecular weight heparin affect fibrin structure and angiogenesis in vitro. Cancer Res 2000; 60: 6196-200.
27. Mousa SA, Mohamed S. Inhibition of endothelial cell tube formation by the low molecular weight heparin, tinzaparin, is mediated by tissue factor pathway inhibitor. Thromb Haemost 2004; 92: 627-33.
28. Scholz D, et al. Contribution of arteriogenesis and angiogenesis to postocclusive hindlimb perfusion in mice. J Mol Cell Cardiol 2002; 34: 775-87.
29. Brevetti LS, et al. Exercise-induced hyperemia unmasks regional blood flow deficit in experimental hindlimb ischemia. J Surg Res 2001; 98: 21-6.
30. Walder CE, et al. Vascular endothelial growth factor augments muscle blood flow and function in a rabbit model of chronic hindlimb ischemia. J Cardiovasc Pharmacol 1996; 27: 91-8.